HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Motohiro Imano Selected Research

Squamous Cell Carcinoma of Head and Neck

3/2021FTI-277 and GGTI-289 induce apoptosis via inhibition of the Ras/ERK and Ras/mTOR pathway in head and neck carcinoma HEp-2 and HSC-3 cells.
1/2017The sensitivity of head and neck carcinoma cells to statins is related to the expression of their Ras expression status, and statin-induced apoptosis is mediated via suppression of the Ras/ERK and Ras/mTOR pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Motohiro Imano Research Topics

Disease

45Neoplasms (Cancer)
04/2024 - 01/2002
41Stomach Neoplasms (Stomach Cancer)
07/2023 - 01/2002
24Neoplasm Metastasis (Metastasis)
05/2024 - 08/2010
14Esophageal Neoplasms (Esophageal Cancer)
05/2024 - 07/2003
11Multiple Myeloma
02/2020 - 10/2012
5Esophageal Squamous Cell Carcinoma
01/2023 - 04/2013
5Melanoma (Melanoma, Malignant)
12/2021 - 01/2015
5Colorectal Neoplasms (Colorectal Cancer)
11/2019 - 08/2010
4Carcinoma (Carcinomatosis)
03/2021 - 12/2013
4Traumatic Brain Injuries (Traumatic Brain Injury)
05/2013 - 02/2010
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2021 - 04/2012
3Breast Neoplasms (Breast Cancer)
10/2018 - 09/2013
3Stomatitis
02/2018 - 05/2014
3Osteoporosis
02/2014 - 03/2012
2Squamous Cell Neoplasms (Squamous Cell Cancer)
04/2024 - 01/2023
2Gastroesophageal Reflux (GERD)
01/2024 - 07/2021
2Neoplasm Micrometastasis
01/2022 - 01/2021
2Lung Neoplasms (Lung Cancer)
01/2022 - 01/2014
2Squamous Cell Carcinoma of Head and Neck
03/2021 - 01/2017
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2020 - 06/2017
2Multiple Sclerosis
09/2020 - 10/2014
2Psoriasis (Pustulosis Palmaris et Plantaris)
09/2020 - 10/2014
2Malnutrition (Nutritional Deficiencies)
03/2020 - 11/2017
2Deglutition Disorders (Dysphagia)
03/2020 - 04/2004
2Proteinuria
02/2019 - 11/2017
2Hypoxia (Hypoxemia)
01/2019 - 10/2012
2Hyperalgesia
10/2018 - 01/2018
2B-Cell Lymphoma (Lymphoma, B Cell)
04/2018 - 10/2014
2Mucositis
02/2018 - 05/2014
2Ascites
11/2017 - 11/2007
2Cognitive Dysfunction
05/2013 - 01/2013
2Lithiasis
01/2010 - 01/2008
2Gallstones (Gallstone)
01/2010 - 01/2009
1Hemorrhage
01/2024
1Foreign-Body Reaction
12/2022

Drug/Important Bio-Agent (IBA)

21Paclitaxel (Taxol)FDA LinkGeneric
05/2022 - 03/2008
10Cisplatin (Platino)FDA LinkGeneric
04/2024 - 04/2012
7Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2008
6Docetaxel (Taxotere)FDA Link
04/2024 - 11/2007
6Fluorouracil (Carac)FDA LinkGeneric
04/2024 - 04/2012
5Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2022 - 07/2015
5NF-kappa B (NF-kB)IBA
09/2020 - 01/2015
5SurvivinIBA
03/2020 - 10/2012
5Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2019 - 08/2011
5OsteopontinIBA
11/2011 - 01/2009
4mangiferinIBA
06/2016 - 01/2015
4Free RadicalsIBA
05/2013 - 12/2011
3Antineoplastic Agents (Antineoplastics)IBA
03/2021 - 08/2011
3Imatinib Mesylate (Gleevec)FDA Link
11/2020 - 06/2017
3Melphalan (Alkeran)FDA LinkGeneric
02/2020 - 10/2012
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2019 - 03/2012
3Phosphotransferases (Kinase)IBA
01/2019 - 01/2016
3Vincristine (Oncovin)FDA LinkGeneric
10/2018 - 04/2015
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018 - 01/2002
3Monoclonal AntibodiesIBA
03/2014 - 12/2012
3titanium silicide (TS-1)IBA
03/2014 - 10/2007
3Diphosphonates (Bisphosphonates)IBA
02/2014 - 03/2012
2CreatinineIBA
01/2023 - 02/2019
2Capecitabine (Xeloda)FDA Link
01/2022 - 01/2020
2AntigensIBA
01/2022 - 01/2014
2Protein Subunit VaccinesIBA
01/2022 - 01/2014
2Peptides (Polypeptides)IBA
01/2022 - 01/2014
2Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
10/2020 - 01/2018
2Dimethyl FumarateIBA
09/2020 - 10/2014
2Verapamil (Calan)FDA LinkGeneric
03/2020 - 01/2014
2Dasatinib (BMS 354825)FDA Link
03/2020 - 02/2019
2RamucirumabIBA
02/2019 - 11/2017
2RANK LigandIBA
02/2019 - 09/2013
2Caspase 3 (Caspase-3)IBA
01/2019 - 01/2017
2Bortezomib (Velcade)FDA Link
10/2018 - 01/2018
2TamoxifenFDA LinkGeneric
10/2018 - 07/2015
2hange-shashintoIBA
01/2018 - 05/2014
2Tyrosine Kinase InhibitorsIBA
06/2017 - 04/2013
2LentinanIBA
01/2016 - 01/2010
2Trastuzumab (Herceptin)FDA Link
06/2015 - 12/2012
2Interleukin-6 (Interleukin 6)IBA
01/2015 - 10/2012
2human ERBB2 proteinIBA
03/2014 - 12/2012
2Irinotecan (Camptosar)FDA LinkGeneric
02/2014 - 01/2007
2geranylgeranyl pyrophosphate (geranylgeranyl diphosphate)IBA
01/2013 - 08/2011
2NitrogenIBA
01/2013 - 03/2012
2Messenger RNA (mRNA)IBA
03/2012 - 01/2009
2Glycoproteins (Glycoprotein)IBA
01/2010 - 01/2008

Therapy/Procedure

31Drug Therapy (Chemotherapy)
07/2023 - 01/2010
27Therapeutics
01/2022 - 01/2007
10Neoadjuvant Therapy
04/2024 - 11/2017
10Gastrectomy
07/2021 - 01/2012
6Esophagectomy
05/2024 - 07/2003
4Lymph Node Excision (Lymph Node Dissection)
05/2024 - 07/2003
4Combination Drug Therapy (Combination Chemotherapy)
12/2019 - 02/2013
3Catheters
12/2022 - 12/2018
3Chemoradiotherapy
10/2021 - 01/2017
3Jejunostomy
11/2020 - 11/2014
3Laparotomy
12/2018 - 11/2007
3TP protocol
10/2018 - 02/2013
2Operative Time
01/2024 - 07/2021
2Palliative Care (Palliative Therapy)
07/2023 - 04/2004
2Intravenous Administration
01/2019 - 09/2012
2Molecular Targeted Therapy
01/2019 - 04/2013
2Adjuvant Chemotherapy
11/2017 - 11/2017
1Transjugular Intrahepatic Portasystemic Shunt
01/2024